1–7 of 7 results for mitochondria
MIDD (Maternally Inherited Diabetes and Deafness) - Right AF
John S. King, MD
Retina Image Bank: Images of the Week
2024
LIGHTSITE III Analysis: 24-Month Evaluation of Multiwavelength Photobiomodulation
Nathan C. Steinle, MD
Updates from the Field
Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study
Priyatham (Prithu) S Mettu, MD
2019
Elamipretide, a Mitochondrial-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with High Risk Drusen
Michael J Allingham, MD, PhD
Annual Meeting Talks
Mitochondria-Targeted Drug Elamipretide for Treatment of Vision Loss in Dry AMD With Noncentral Geographic Atrophy
Scott W. Cousins, MD
Episode 162: April 2019 Retinal Physician Preview Discussion of AMD Topics with Dr. Margaret Greven and Dr. M. Ali Khan
Jayanth Sridhar, MD
Member Podcasts
2018
Elamipretide, a Mitochondria-Targeted Drug for the Treatment of Vision Loss